Form 4: Verizon Exec Kyle Malady Granted 84,926 RSUs

Verizon Communications Inc. EVP and Group CEO-VZ Business, Kyle Malady, was granted 84,926 Restricted Stock Units vesting on December 31, 2027.

Summary

• Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., acquired 84,926 Special Restricted Stock Units (RSUs).
• Each RSU represents the right to receive one share of common stock, plus accrued dividends, upon vesting.
• The RSUs were granted on February 4, 2026, and are scheduled to vest on December 31, 2027.
• The acquisition price for these derivative securities was $0, which is typical for RSU grants.
• Following this transaction, Kyle Malady directly beneficially owns 84,926 derivative securities.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices designed to align management incentives with long-term company performance.

Positives

• The grant of 84,926 Restricted Stock Units to a key executive, Kyle Malady, aligns his interests with long-term shareholder value.
• The RSUs include accrued dividends, providing additional value upon vesting.

Risks

• The value of the RSUs is subject to the future performance of Verizon's common stock until vesting.
• Vesting is subject to the terms of the RSU Agreement, which may include continued employment or performance conditions not detailed in this filing.

Future Outlook

The grant of Restricted Stock Units to a key executive suggests a long-term incentive strategy, aligning management's future performance with shareholder returns through equity ownership.

Industry Context

StockSavvy.ai notes that equity grants, particularly Restricted Stock Units, are a standard component of executive compensation packages across the telecommunications industry. This practice aims to incentivize long-term performance and retention of key talent, similar to practices at AT&T (T) or T-Mobile (TMUS).

Comparison to Industry Standards

• The grant of RSUs is a common executive compensation tool, aligning with practices seen at major telecommunications companies globally, such as AT&T, Vodafone, and Deutsche Telekom.
• The vesting schedule, while not fully detailed beyond the date, is typical for long-term incentive plans designed to retain executives over several years.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns executive interests with shareholder value, potentially leading to better long-term performance. It also represents potential future dilution upon vesting, though this is a standard part of equity compensation.
• Employees: This transaction highlights the company's executive compensation structure, which can influence broader employee incentive programs.

Next Steps

• The RSUs are scheduled to vest on December 31, 2027, at which point Kyle Malady will receive shares of Verizon common stock.

Key Dates

Recommendation

This Form 4 reports a routine executive equity grant, which is a standard part of compensation and incentive alignment. It does not provide new information that would fundamentally alter the investment thesis for Verizon, hence a 'hold' recommendation is appropriate for existing investors. New investors would need to consider broader company fundamentals.

Keywords

Verizon, VZ, Kyle Malady, Restricted Stock Units, RSU, Executive Compensation, Equity Grant, SEC Form 4, Insider Transaction